MX2022004349A - Comprimido de disolucion bucal de nicotina. - Google Patents

Comprimido de disolucion bucal de nicotina.

Info

Publication number
MX2022004349A
MX2022004349A MX2022004349A MX2022004349A MX2022004349A MX 2022004349 A MX2022004349 A MX 2022004349A MX 2022004349 A MX2022004349 A MX 2022004349A MX 2022004349 A MX2022004349 A MX 2022004349A MX 2022004349 A MX2022004349 A MX 2022004349A
Authority
MX
Mexico
Prior art keywords
module
lozenge
compressed
nicotine lozenge
nicotine
Prior art date
Application number
MX2022004349A
Other languages
English (en)
Inventor
Heidi Ziegler Bruun
Dorthe Schackinger Boesen
Bruno Provstgaard Nielsen
Kent Albin Nielsen
Rikke Pranger-Rasmussen
Original Assignee
Fertin Pharma As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fertin Pharma As filed Critical Fertin Pharma As
Publication of MX2022004349A publication Critical patent/MX2022004349A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465—Nicotine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Physiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Se describe un comprimido hidrosoluble de disolución bucal de nicotina oral, el comprimido de disolución bucal de nicotina oral comprende un primer módulo y un segundo módulo, el primero y el segundo módulo se fusionan por compresión, el primer módulo es un módulo del comprimido de disolución bucal que comprende al menos un alcohol de azúcar y el segundo módulo es un módulo FDT que comprende al menos un alcohol de azúcar y nicotina. También se describe un método de fabricación de un comprimido hidrosoluble de disolución bucal de nicotina oral.
MX2022004349A 2019-10-11 2020-04-17 Comprimido de disolucion bucal de nicotina. MX2022004349A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16/599,629 US11759419B2 (en) 2019-10-11 2019-10-11 Compressed nicotine lozenge
PCT/DK2020/050103 WO2021069036A1 (en) 2019-10-11 2020-04-17 Compressed nicotine lozenge

Publications (1)

Publication Number Publication Date
MX2022004349A true MX2022004349A (es) 2022-06-08

Family

ID=70464804

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2022004349A MX2022004349A (es) 2019-10-11 2020-04-17 Comprimido de disolucion bucal de nicotina.

Country Status (10)

Country Link
US (2) US11759419B2 (es)
EP (1) EP3923910B1 (es)
JP (1) JP2022551314A (es)
KR (1) KR20220080165A (es)
CN (1) CN114630653A (es)
AU (2) AU2020363748B2 (es)
BR (1) BR112022006691A2 (es)
CA (1) CA3154225A1 (es)
MX (1) MX2022004349A (es)
WO (1) WO2021069036A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20220354785A1 (en) * 2021-04-22 2022-11-10 Nicoventures Trading Limited Oral lozenge products
WO2024156906A1 (en) * 2023-01-27 2024-08-02 Philip Morris Products S.A. System for oral delivery of an active ingredient
WO2024156325A1 (en) * 2023-01-27 2024-08-02 Fertin Pharma A/S Dissolvable orally adhering nicotine tablet

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CL2009001025A1 (es) * 2008-05-01 2010-09-24 Smithkline Beecham Corp Composicion de pastilla para chupar que comprende: a) un granulo patron con al menos: un agente tampon alcalino, un modificador de la disolucion y una carga, b) un principio activo de nicotina definido extragranular y al menos un agente tampon alcalino; procedimiento de preparacion; util para eliminar o reducir el uso de tabaco.
WO2010044736A1 (en) * 2008-10-14 2010-04-22 Mcneil Ab Multi portion intra-oral dosage form and use thereof
RU2530655C2 (ru) 2009-04-24 2014-10-10 Омиа Интернэшнл Аг Материал в виде частиц для контролируемого высвобождения активных ингредиентов
US10543205B2 (en) 2016-11-18 2020-01-28 Fertin Pharma A/S Oral delivery vehicle containing nicotine
AU2018273539B2 (en) 2017-05-22 2024-03-21 Johnson & Johnson Consumer Inc. Lozenge dosage form

Also Published As

Publication number Publication date
AU2020363748A1 (en) 2022-04-28
KR20220080165A (ko) 2022-06-14
CA3154225A1 (en) 2021-04-15
CN114630653A (zh) 2022-06-14
EP3923910B1 (en) 2024-09-11
JP2022551314A (ja) 2022-12-08
BR112022006691A2 (pt) 2022-07-12
AU2024201729A1 (en) 2024-04-04
EP3923910A1 (en) 2021-12-22
AU2020363748B2 (en) 2024-04-11
US11759419B2 (en) 2023-09-19
US20210106521A1 (en) 2021-04-15
US20240000706A1 (en) 2024-01-04
WO2021069036A1 (en) 2021-04-15

Similar Documents

Publication Publication Date Title
MX2022004349A (es) Comprimido de disolucion bucal de nicotina.
GB2473798A (en) Systems and methods for intra-oral based communications
MY194177A (en) Wafer processing method
MY192243A (en) Wafer processing method
EP4131773C0 (en) PHOTOVOLTAIC FRAME, PHOTOVOLTAIC MODULE AND METHOD FOR MANUFACTURING PHOTOVOLTAIC FRAME
EP3757603A4 (en) DISTANCE MEASURING SYSTEM, LIGHT RECEIVING MODULE AND METHOD FOR MANUFACTURING A BAND PASS FILTER
EP3894936A4 (en) AR HEADPHONE OPTICAL SYSTEM AND METHOD OF DESIGN AND MANUFACTURING
EP3971994A4 (en) PHOTOVOLTAIC MODULE, BACKING FILM OF A PHOTOVOLTAIC MODULE AND METHOD OF MANUFACTURING A PHOTOVOLTAIC MODULE
DK1841285T3 (da) Höreapparatsystem med binaural dataregistrering og en tilsvarende fremgangsmåde
MY192244A (en) Wafer processing method
MX2020014278A (es) Dispositivo de fragmentacion para fragmentar el vidrio de una ventana.
EP3865930A4 (en) OPHTHALMIC LENS, METHOD FOR DESIGNING IT, METHOD FOR MANUFACTURING IT AND SET OF OPHTHALMIC LENSES
EP4080263A4 (en) CAMERA MODULE, SPACER COMPONENT AND METHOD OF MAKING A CAMERA MODULE
EP4039677A4 (en) PROCESS FOR PRODUCING PERFLUORO(2,4-DIMETHYL-2-FLUOROFORMY -1,3-DIOXOLANE)
EP4033548A4 (en) SUBMINIATURE OPTICAL TRANSMISSION MODULE AND METHOD FOR PRODUCING THEREOF USING A SEMICONDUCTOR ENCAPSULATION SCHEME
EP4135057A4 (en) THERMOELECTRIC TRANSDUCER, THERMOELECTRIC MODULE, BINDER AND METHOD FOR MANUFACTURING THERMOELECTRIC TRANSDUCER
WO2003063681A3 (en) Method and compound for the prophylaxis or treatment of an immunodeficiency condition, such as aids
EP3958314A4 (en) SEMI-CONDUCTOR STRUCTURE AND METHOD OF MANUFACTURING IT
EP4102592A4 (en) DOPING SYSTEM AND ELECTRODE MANUFACTURING METHOD
PL3926693T3 (pl) Część funkcjonalna, moduł fotowoltaiczny i sposób wytwarzania modułu fotowoltaicznego
EP3989038A4 (en) MULTICORE SYNCHRONOUS SIGNAL GENERATION CIRCUIT, CHIP, AND SYNCHRONIZATION METHOD AND DEVICE
WO2019004702A3 (ko) 기능성 감미료의 제조방법
EP4004465A4 (en) ADIABATIC VACUUM MODULE, REFRIGERATOR AND METHOD OF MAKING THE REFRIGERATOR
MX2024007186A (es) Comprimido de nicotina.
EP3778544A4 (en) PROCESS FOR THE PREPARATION OF 1,4-CYCLOHEXANEDICARBONIC ACID DERIVATIVE, 1,4-DICYANOCYCLOHEXANE AND 1,4-BIS (AMINOMETHYL) CYCLOHEXANE